Nanox Imaging Ltd. (NASDAQ: NNOX) has scheduled the release of its financial results for the quarter ended June 30, 2026, before the market opens on September 9, 2026. The announcement, made via press release, underscores the company's ongoing efforts to transform medical imaging and preventive healthcare. Following the release, CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call at 8:30 a.m. ET to review the results and provide a business update. The call will be accompanied by a live webcast accessible through the Investor Relations section of the Nanox website, ensuring broad accessibility for shareholders and interested parties.
This forthcoming financial report is significant for investors and the healthcare industry alike, as it will offer a detailed look into Nanox's performance and strategic direction. The company is at the forefront of driving the world's transition to preventive healthcare through its end-to-end medical imaging and healthcare services platform. By integrating affordable imaging hardware, advanced AI-based solutions, cloud-based software, remote radiology access, health IT solutions, and a marketplace, Nanox aims to enable earlier detection, improve clinical efficiency, and broaden access to care.
The core of Nanox's ecosystem includes the Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis system designed for scalability and ease of use. Complementing this hardware are Nanox.AI algorithms that augment routine CT imaging interpretation to identify early signs of chronic disease, and Nanox.CLOUD, a secure platform for data management and advanced analytics. The company also operates Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts, and Nanox Health IT, which offers RIS, PACS, AI, dictation, and secure infrastructure solutions to streamline workflows.
Investors will be keen to hear management's commentary on the adoption of these technologies and any developments in the company's commercial strategy. The upcoming call presents an opportunity to gauge progress on Nanox's vision to expand medical imaging beyond traditional hospital settings, potentially lowering barriers to adoption and improving utilization worldwide. The latest news and updates on NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
The financial results and subsequent business update will provide crucial data points for assessing Nanox's trajectory in a competitive medical technology landscape. As the company continues to innovate and integrate its offerings, the September 9 report will be a key indicator of its progress toward making preventive healthcare a global reality.
